Zynteglo

US government declines to clear Bluebird fertility support for Zynteglo patients
BioPharma Dive
Mon, 07/22/24 - 06:54 pm
Bluebird Bio
Zynteglo
HHS
Fertility
5 FDA decisions to watch in the fourth quarter
BioPharma Dive
Mon, 10/2/23 - 12:00 pm
FDA
Alnylam
Onpattro
ATTR amyloidosis
Vertex Pharmaceuticals
CRISPR Therapeutics
exa-cel
Bluebird Bio
Zynteglo
sickle cell disease
Bristol Myers Squibb
2seventy bio
Abecma
Multiple Myeloma
Amgen
Lumakras
non-small cell lung cancer
Pfizer
estrasimod
ulcerative colitis
Bluebird touts Zynteglo, Skysona launch progress as FDA decision on sickle cell therapy nears
Fierce Pharma
Tue, 08/8/23 - 11:33 am
Bluebird Bio
Zynteglo
Skysona
FDA
sickle cell disease
gene therapy
ASH: Despite partial clinical hold, bluebird's sickle cell gene therapy remains on track
Fierce Pharma
Sun, 12/11/22 - 01:34 pm
Bluebird Bio
ASH 2022
Zynteglo
sickle cell disease
gene therapy
lovo-cel
Gene therapy is saving lives, but key challenges to realize its full potential
MedCity News
Thu, 10/20/22 - 10:30 am
gene therapy
Novartis
Zolgensma
Roctavian
Zynteglo
Skysona
bluebird bio Scores First U.S. Approval for Lentiviral Vector Gene Therapy
BioSpace
Wed, 08/17/22 - 11:34 pm
Bluebird Bio
FDA
gene therapy
beta thalassemia
Zynteglo
beti-cel
JPM 2022: Bluebird CEO sees 'unfinished business' with Zynteglo in Europe, but scale-up needed first
Fierce Pharma
Tue, 01/11/22 - 11:31 am
Bluebird Bio
JPMHC 2022
Pharma CEOs
Europe
Zynteglo
Bluebird bio may finally get a gene therapy approved in the US
Endpoints
Mon, 11/22/21 - 10:28 am
Bluebird Bio
gene therapy
FDA
Zynteglo
beta-thalassemia
priority review
With LentiGlobin cleared by FDA, bluebird lifts EU marketing hold on gene therapy using the same delivery mechanism
Endpoints
Fri, 07/9/21 - 09:54 am
Bluebird Bio
LentiGlobin
sickle cell disease
Zynteglo
Europe
beta thalassemia
Bluebird's Zynteglo trials set to resume, putting gene therapy back on flight path to FDA filing
Fierce Pharma
Mon, 06/7/21 - 11:09 am
Bluebird Bio
Zynteglo
gene therapy
beta-thalassemia
Bluebird bio lays off staffers in Europe as Zynteglo rollout hits an early reimbursement snag
Fierce Pharma
Tue, 04/20/21 - 07:38 pm
Bluebird Bio
Zynteglo
reimbursement
layoffs
Germany
gene therapy
EMA begins safety review of bluebird gene therapy following AML case in related therapy
Endpoints
Fri, 03/12/21 - 10:32 am
Bluebird Bio
Zynteglo
Europe
EMA
AML
Bluebird’s Zynteglo safety snag could spell trouble for other gene therapies: analysts
Fierce Pharma
Thu, 02/18/21 - 09:52 pm
gene therapy
Bluebird Bio
Zynteglo
clinical trials
Bluebird gets European green light for gene therapy production
Biopharma Dive
Fri, 10/25/19 - 10:34 am
Bluebird Bio
gene therapy
Europe
Zynteglo
bluebird bio Prepares for Launch
Motley Fool
Thu, 08/8/19 - 10:22 am
Bluebird Bio
Zynteglo
beta-thalassemia
drug launches
Where Will bluebird bio Be in 1 Year?
Motley Fool
Fri, 06/21/19 - 09:58 am
Bluebird Bio
bb2121
Zynteglo
What Bluebird Bio Gets Wrong In Pricing For Its $1.8 Million Drug
Forbes
Wed, 06/19/19 - 09:55 am
Bluebird Bio
gene therapy
drug pricing
Zynteglo
beta thalassemia
Bluebird delays gene therapy launch to 2020, citing manufacturing tweaks
Biopharma Dive
Tue, 06/18/19 - 11:57 am
Bluebird Bio
gene therapy
drug manufacturing
Zynteglo
bluebird offers installment payments for Zynteglo gene therapy
Pharmaforum
Mon, 06/17/19 - 12:25 pm
Bluebird Bio
outcome-based pricing
drug pricing
gene therapy
Zynteglo
beta thalassemia
Is $1.8 Million for bluebird bio's New Gene Therapy Ridiculous?
Motley Fool
Sat, 06/15/19 - 05:49 pm
Bluebird Bio
Zynteglo
drug pricing
beta thalassemia

Pages